30th Nov 2006 18:03
Protherics PLC30 November 2006 Protherics PLC Notification of Major Interest in Shares London, UK; Brentwood, TN; 30 November 2006 - Protherics PLC ("Protherics" orthe "Company"), the international biopharmaceutical company focused on criticalcare and cancer, announces that, on 29 November 2006, it received notificationfrom Aviva plc that, as at 27 November 2006, Aviva plc and its subsidiaries heldan interest in 31,441,191 ordinary shares, representing 12.02% of the issuedshare capital of the Company The Shares are represented by a beneficial interest in 17,502,185 ordinaryshares (6.69%) and a non-beneficial interest in 13,939,006 ordinary shares(5.33%). This notification follows the purchase of 105,500 ordinary shares on 27 November2006 representing 0.04% of the issued share capital of the Company. The issued share capital of the Company is 261,487,953 ordinary shares. | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, David Yates +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Aviva